Express News | Sihuan Pharma - Will Conduct on-Market Share Repurchase of up to HK$500 Mln in Aggregate

ReutersApr 28 08:57 ET

SIHUAN PHARM (00460.HK) spent 10.887 million HKD to repurchase 16.174 million shares on April 28.

On April 28, Gelonghui announced that SIHUAN PHARM (00460.HK) spent HKD 10.887 million to repurchase 16.174 million shares.

Gelonghui FinanceApr 28 05:57 ET

SIHUAN PHARM: ANNUAL REPORT 2024

HKEXApr 28 05:00 ET · Announcements

Hong Kong stock market movement | SIHUAN PHARM (00460) rises over 4%, its polylactic acid facial filler "Youthful Needle" has been approved for上市.

SIHUAN PHARM (00460) rose over 4%, as of the time of writing, it increased by 4.55%, priced at 0.69 HKD, with a transaction volume of 26.8874 million HKD.

Zhitong FinanceApr 28 02:43 ET

Sihuan Pharmaceutical Unit Gets China Nod for Registration of Facial Filler

MT NewswiresApr 28 02:29 ET

Hong Kong Stock Announcement Gold Mining | BYD Company (01211) reported a net income of 9.155 billion yuan in the first quarter, an increase of 100.38% year-on-year.

SIHUAN PHARM (00460): The facial filler (child's face needle) independently developed by Meiyan Space has obtained market approval from the National Medical Products Administration; GRANDPHARMA (00512): The early detection product for urological tumors has achieved its first commercial prescription in mainland China.

Zhitong FinanceApr 27 07:37 ET